PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.77%
Negative revenue growth while Healthcare median is 0.00%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-6.75%
Negative gross profit growth while Healthcare median is 0.00%. Seth Klarman would suspect poor product pricing or inefficient production.
-31.49%
Negative EBIT growth while Healthcare median is 0.00%. Seth Klarman would check if external or internal factors caused the decline.
-35.54%
Negative operating income growth while Healthcare median is 0.00%. Seth Klarman would check if structural or cyclical issues are at play.
-32.23%
Negative net income growth while Healthcare median is 0.00%. Seth Klarman would investigate factors dragging net income down.
-32.22%
Negative EPS growth while Healthcare median is 0.00%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-32.22%
Negative diluted EPS growth while Healthcare median is 0.00%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
58.88%
10Y CAGR of 58.88% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound over very long horizons.
-14.93%
Negative 5Y CAGR while Healthcare median is 0.00%. Seth Klarman would see if others are at least growing moderately, indicating a firm-specific problem.
36.94%
3Y CAGR of 36.94% while Healthcare median is zero. Walter Schloss might see a modest improvement overshadowing the broader sector’s stagnation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
127.10%
Net income/share CAGR exceeding 1.5x Healthcare median of 2.12% over a decade. Joel Greenblatt might see a standout compounder of earnings.
-26.01%
Negative 5Y CAGR while Healthcare median is 0.00%. Seth Klarman might see a specific weakness if peers maintain profitable expansions.
18.92%
3Y net income/share CAGR > 1.5x Healthcare median of 5.11%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
175.31%
Equity/share CAGR of 175.31% while Healthcare median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
21.78%
5Y equity/share CAGR of 21.78% while Healthcare median is zero. Walter Schloss sees a slight positive that might compound if management executes well.
68.66%
3Y equity/share CAGR of 68.66% while Healthcare median is zero. Walter Schloss sees a modest short-term advantage that could compound if momentum persists.
No Data
No Data available this quarter, please select a different quarter.
12.50%
5Y dividend/share CAGR of 12.50% while Healthcare is zero. Walter Schloss sees at least some improvement that could compound over time.
-18.18%
Dividend reductions while Healthcare median grows. Seth Klarman sees a near-term disadvantage if peers maintain or raise payouts.
8.70%
AR growth of 8.70% while Healthcare median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
9.23%
Inventory growth of 9.23% while Healthcare median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
1.72%
Asset growth of 1.72% while Healthcare median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
3.25%
BV/share growth of 3.25% while Healthcare is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
-7.42%
Debt is shrinking while Healthcare median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
1.66%
SG&A growth of 1.66% while Healthcare median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.